https://www.selleckchem.com/pr....oducts/ap-3-a4-enobl
Oseltamivir is frequently administered to critically ill patients with presumed influenza. It may modulate Na , K , and Ca channels to produce bradycardia. To evaluate the association between oseltamivir and bradycardia in critically ill patients and assess parameters associated with bradycardia. This was a retrospective audit of 203 critically ill adults with presumed influenza receiving at least 2 doses of oseltamivir. The primary outcome was the occurrence of bradycardia, defined as a heart rate (HR) ≤59 beats per minute (BP
Curtir
Comentario
Compartilhar
